化疗药物联合过氧化物酶体增殖物激活受体(PPAR)的配体能够协同抑制肺细胞癌及卵巢癌细胞。
Chemotherapy given in combination with ligands for the peroxisome proliferator-activated receptor - (PPAR) synergistically inhibits the growth of lung and ovarian cancer cell lines.
其他一些药物包括H - 2受体阻断剂(雷尼替丁或法莫替丁)，可以抑制胃酸的分泌减少胃内容物。
Other pharmacologic agents include the H2-receptor blockers (ranitidine or famotidine), which inhibit gastric acid production and decrease gastric volume.
作为天然核苷受体的竞争性抑制剂，糖环部分化学改造的核苷类似物在过去的几十年中得到了深入的研究。
As competitive inhibitors of natural nucleoside receptors, sugar-modified nucleoside analogues have been well studied in the past few decades.
结论：连钱草乙醇提取物具有抑制肠蠕动作用，这种作用可能由胃肠道的胆碱能受体和组胺受体介导，或直接作用于回肠平滑肌细胞。
CONCLUSIONS EGLK has the inhibition effect on intestine peristalsis which may be mediated through cholinoceptor and histamine receptor or directly ACTS on the cells of ileum smooth muscle.
本发明涉及某些喹啉化合物，其用作神经激肽- 1 (NK - 1)受体拮抗剂，和速激肽及特别是P物质抑制剂。
The present invention is directed to certain quinoline compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance p.
本发明涉及某些内酰胺化合物，其适用作神经激肽- 1 (NK - 1)受体拮抗剂，速激肽特别是P物质抑制剂。
The present invention is directed to certain lactam compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance p.
表皮生长因子受体的三维结构通过同源蛋白模建的方法得到，而抑制剂和靶酶结合复合物结构则通过分子力学和分子动力学结合的方法计算得到。
The 3d structure of EGFR was constructed using homology modeling, and the complex structures between receptor and ligands were predicted by using molecular mechanics and molecular dynamics.
表皮生长因子受体的三维结构通过同源蛋白模建的方法得到，而抑制剂和靶酶结合复合物结构则通过分子力学和分子动力学结合的方法计算得到。
The 3d structure of EGFR was constructed using homology modeling, and the complex structures between receptor and ligands were predicted by using molecular mechanics and molecular dynamics.
应用推荐